Here the authors show that Plasmodium falciparum egress products disrupt endothelial barrier and activate JAK-STAT and interferon type response in a 3D blood-brain barrier model. Vascular disruption is reversed by Ruxolitinib, a JAK-STAT inhibitor.
- Livia Piatti
- Alina Batzilla
- Maria Bernabeu
